All Articles

Facing a 50% revenue collapse and mounting losses, The Arena Group is rebranding to Paradium.AI, a high-stakes pivot to save itself with technology.

Tactile Medical's impressive Q2 profit growth is tempered by a product launch stumble, testing its execution as it places big bets on new markets and tech.

Fluent's Q2 results reveal a dramatic pivot, with Commerce Media Solutions booming 90%. But can this growth and a new in-store bet outrun a stark 'going concern' warning?

Beyond the hype of AI models and drones, Kopin is building the critical optical networks and displays that make them possible. A look at its strategic Q2.

Entravision's ad-tech unit soared 230% on AI, driving record profit. But with its legacy media arm in decline, can this tech pivot redefine its future?

Angie O'Leary's promotion at Commercial Vehicle Group is more than a new title. It's a strategic bet on continuity to navigate a turbulent EV transition.

Sumisho Air Lease reports a 98% profit drop in its first post-acquisition quarter, but accounting shifts mask a deeper strategic realignment for the lessor.

In a blockbuster deal with Boeing, Archer acquires key assets to build a 'physical AI' powerhouse. But with soaring losses, is it a masterstroke or a costly bet?

Alico's Q3 results reveal a successful pivot from citrus giant to land developer, with profits soaring and major projects advancing. How is this changing Florida?

P3 Health Partners stuns Wall Street with a swing to profitability, but a deeper dive reveals one-time gains and a strategic pivot. Is this the new playbook?

BODi posts a fourth straight profitable quarter, but with revenue and subscribers in freefall, is its dramatic cost-cutting a sign of health or stagnation?

Metagenomi Therapeutics is on track for a pivotal 2027 clinical trial, but its advanced gene editing tech faces a market wary of high-cost cures.

Amidst declining revenue and layoffs, Rapid7's new CEO is making a bold bet on a focused, AI-driven strategy. Is this the path to renewed strength?

Strong Attruby sales and new data showing superiority fuel BridgeBio’s momentum as it prepares for three FDA decisions, backed by a new $1B financing.

Wah Fu Education's stock soared after announcing a radical pivot to enterprise AI. But can custom models for agriculture and medicine save a struggling company?

A Texas tech firm just earned a major security certification for its AI. It's more than a press release—it's a blueprint for building trust in an industry on edge.

As med spa fillir launches its largest-ever expansion into new markets, its success hinges not on speed, but on a rigorous physician-led model and proprietary training.

A new study reveals small businesses are highly aware of cyber threats, yet a deeper look shows a gap between planning and true resilience. Why is a bank leading this charge?

Two years after a landmark rejection, the bid to approve MDMA-assisted therapy for PTSD is back. This is more than a resubmission; it's a test case for a new paradigm in medicine.

TextUs's new WhatsApp integration tackles communication silos, offering a unified inbox that automates compliance and promises to boost global B2B performance.